Adenosine 5′-triphosphate (ATP) is an excitatory cotransmitter with noradrenaline to the smooth muscle of the rat prostate gland

British Journal of Pharmacology

Volumn 138, Issue 7, 2003, Pages 1277-1284

  Ventura, Sabatino ^a   Dewalagama, Ramila K ^a   Lau, Linda C L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adenosine 5 triphosphate; ATP; Cotransmission; Neuromuscular transmission; P2X receptors; Prostate; Smooth muscle; Stroma; Sympathetic nervous system

Indexed keywords

ADENOSINE TRIPHOSPHATE; EXCITATORY AMINO ACID RECEPTOR; NORADRENALIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ALPHA,BETA-METHYLENEADENOSINE 5'-TRIPHOSPHATE; DRUG DERIVATIVE; PRAZOSIN; PURINE NUCLEOTIDE; PURINE P2 RECEPTOR; PURINE RECEPTOR; SURAMIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EVOKED RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE FIBER; STROMA CELL; SYMPATHETIC NERVE; ANIMAL; DRUG EFFECT; ELECTROSTIMULATION; METABOLISM; NERVE ENDING; PHYSIOLOGY; PROSTATE; SMOOTH MUSCLE; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ELECTRIC STIMULATION; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH; NERVE ENDINGS; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PRAZOSIN; PROSTATE; PURINE NUCLEOTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC; RECEPTORS, PURINERGIC P2; SURAMIN;

EID: 0037739763     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705167     Document Type: Article

References (25)

1. ABBRACCHIO, M.P. & BURNSTOCK, G. (1998). Purinergic signalling: pathophysiological roles. Jpn. J. Pharmacol., 78, 113-145.
2. 3H]α,βmethylene ATP binding sites in urinary bladder and urethra of rat, guinea-pig and rabbit. Eur. J. Pharmacol., 216, 59-66.
3. 3H]α,βmethylene ATP binding sites in blood vessels. J. Vasc. Res., 30, 87-101.
4. BURNSTOCK, G. (1978). A basis for distinguishing two types of purinergic receptor. In: Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. eds. Straub, R.W. & Bolis, L. pp. 107-118. New York: Raven Press.
5. 2-purinoceptor? Gen. Pharmacol., 16, 433-440.
6. ERI, L.M. & TVETER, K.J. (1995). Alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia. J. Urol., 154, 923-934.
7. EVANS, R.J. & KENNEDY, C. (1994). Characterisation of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. Br. J. Pharmacol., 113, 853-860.
8. 2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma calls. J. Clin. Invest., 89, 191-196.
9. GUIJARRO, L.G., JUARRANZ, M.G., MARINERO, M.J., PAJUELO, L., CARMENA, M.J. & PRIETO, J.C. (1996). Modulation of cyclic AMP and inositol phosphate production in rat prostatic cultures by VIP/PACAP, ATP and carbachol: role in prostatic proliferation. Ann. NY Acad. Sci., 72, 723-728.
10. 1-adrenoceptor antagonists. Pharmacol. Rev. Commun., 8, 251-256.
11. HUMPHREY, P.P.A., KHAKH, B.S., KENNEDY, C., KING, B.F. & BURNSTOCK, G. (1998). P2X receptors. In: The IUPHAR Compendium of Receptor Characterization and Classification. ed. IUPHAR Committee on Receptor Nomenclature and Drug Classification. pp. 58-74. London: IUPHAR Media.
12. INOUE, R. & BRADING, A.F. (1990). The properties of the ATP-induced depolarization and current in single cells isolated from the guinea-pig urinary bladder. Br. J. Pharmacol., 100, 619-625.
13. 1-receptor. Biochem. Biophys. Res. Commun., 221, 588-593.
14. KHAKH, B.S., SURPRENANT, A. & HUMPHREY, P.P. (1995). A study on P2X purinoceptors mediating the electrophysiological and contractile effects or purine nucleotides in rat vas deferens. Br. J. Pharmacol., 115, 177-185.
15. KIRBY, R.S. (1989). Alpha-adrenoceptor inhibitors in the treatment of benign prostatic hyperplasia. Am. J. Med., 87, 26S-30S.
16. KONRAD, L., SCHIEMANN, P., RENNEBERG, H., WENNEMUTH, G., FINI, C. & AUMÜLLER, G. (1998). Expression and enzymatic activity of ecto 5′-nucleotidase in the human male genital tract. Biol. Reprod., 59, 190-196.
17. LAU, W.A.K., VENTURA, S. & PENNEFATHER, J.N. (1998). Pharmacology of neurotransmission to the smooth muscle of the rat and the guinea-pig prostate glands. J. Auton. Pharmacol., 18, 349-356.
18. LEE, H.Y., BARDINI, M. & BURNSTOCK, G. (2000). P2X receptor immunoreactivity in the male genital organs of the rat. Cell Tissue Res., 300, 321-330.
19. 2X1 receptor: molecular cloning, tissue distribution, and localisation to chromosome 17. Biochim. Biophys. Acta, 1308, 185-188.
20. PENNEFATHER, J.N., LAU, W.A.K., MITCHELSON, F. & VENTURA, S. (2000). The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies. J. Auton. Pharmacol., 20, 193-206.
21. PRESTON, A., LAU, W.A.K., PENNEFATHER, J.N. & VENTURA, S. (2000). Effects of adenine nucleosides and nucleotides on neuromuscular transmission to the prostatic stroma of the rat. Br. J. Pharmacol., 131, 1073-1080.
22. 3,4,6 are up-regulated during apoptosis in the ageing rat prostate. Histochem. J., 32, 571-580.
23. VENTURA, S. (1998). Autoinhibition, sympathetic cotransmission and biphasic contractile responses to trains of nerve stimulation in the rodent vas deferens. Clin. Exp. Pharmacol. Physiol., 25, 965-973.
24. VENTURA, S. & PENNEFATHER, J.N. (1991). Sympathetic co-transmission to the cauda epididymis of the rat: characterization of postjunctional adrenoceptors and purinoceptors. Br. J. Pharmacol., 102, 540-544.
25. WASILENKO, W.J., COOPER, J., PALAD, A.J., SOMERS, K.D., BLACKMORE, P.F., RHIM, J.S., WRIGHT Jr, G.L. & SCHELLHAMMER, P.F. (1997). Calcium signalling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP. Prostate, 30, 167-173.